ImprimisRx has just launched three 5ml bottles at strengths of 0.01%, 0.025% and 0.05%. Click image to enlarge.

Growing interest in myopia management is bringing ophthalmic mainstay drug atropine renewed attention, as the agent has a role to play in slowing the condition’s development. Optometrists can now order atropine in one of three concentrations from compounding pharmacy ImprimisRx, which has just launched three 5ml bottles at strengths of 0.01%, 0.025% and 0.05%, each priced at $39. The company says the drops do not contain preservatives or boric acid, have a pH of 5.5 and may be stored at room temperature for up to 180 days.

For more information, visit www.atropine.com.